BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 30801752)

  • 21. The screening and electron microscopy observation of mammary analogue secretory carcinoma in Chinese.
    Zhong Y; Liu L; Qi B; Song X; Shen L; Li H
    J Craniomaxillofac Surg; 2018 Jun; 46(6):893-897. PubMed ID: 29752049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.
    Baghai F; Yazdani F; Etebarian A; Garajei A; Skalova A
    Pathol Res Pract; 2017 Sep; 213(9):1112-1118. PubMed ID: 28781197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.
    Majewska H; Skálová A; Stodulski D; Klimková A; Steiner P; Stankiewicz C; Biernat W
    Virchows Arch; 2015 Mar; 466(3):245-54. PubMed ID: 25503077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland.
    Ito H; Ishida M; Ebisu Y; Okano K; Sandoh K; Noda Y; Miyasaka C; Fujisawa T; Yagi M; Iwai H; Tsuta K
    Diagn Cytopathol; 2021 Aug; 49(8):E329-E335. PubMed ID: 33885200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
    Skálová A; Banečkova M; Thompson LDR; Ptáková N; Stevens TM; Brcic L; Hyrcza M; Michal M; Simpson RHW; Santana T; Michal M; Vaněček T; Leivo I
    Am J Surg Pathol; 2020 Oct; 44(10):1295-1307. PubMed ID: 32675658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
    Ito Y; Ishibashi K; Masaki A; Fujii K; Fujiyoshi Y; Hattori H; Kawakita D; Matsumoto M; Miyabe S; Shimozato K; Nagao T; Inagaki H
    Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-grade salivary gland carcinoma with the ETV6-NTRK3 gene fusion: A case report and literature review of secretory carcinoma with high-grade transformation.
    Asai S; Sumiyoshi S; Yamada Y; Tateya I; Nagao T; Minamiguchi S; Haga H
    Pathol Int; 2021 Jun; 71(6):427-434. PubMed ID: 33848386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
    Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
    Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics.
    Hung YP; Fletcher CDM; Hornick JL
    Histopathology; 2018 Oct; 73(4):634-644. PubMed ID: 29863809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical/unbalanced ETV6/NTRK3 rearrangement in salivary secretory carcinoma with a focus on the incidence, the patterns, and the clinical implications.
    Sun J; Li J; Tian Z; Zhang C; Xia R; He Y
    J Oral Pathol Med; 2022 Sep; 51(8):721-729. PubMed ID: 36087274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.
    Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M
    Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity.
    Rooper LM; Karantanos T; Ning Y; Bishop JA; Gordon SW; Kang H
    Am J Surg Pathol; 2018 Aug; 42(8):1121-1126. PubMed ID: 29683815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rare malignancy of the parotid gland in a 13-year-old Taiwanese boy: case report of a mammary analogue secretory carcinoma of the salivary gland with molecular study.
    Hwang MJ; Wu PR; Chen CM; Chen CY; Chen CJ
    Med Mol Morphol; 2014 Mar; 47(1):57-61. PubMed ID: 23955668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?
    Projetti F; Lacroix-Triki M; Serrano E; Vergez S; Barres BH; Meilleroux J; Delisle MB; Uro-Coste E
    J Oral Pathol Med; 2015 Apr; 44(4):244-51. PubMed ID: 25040635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
    Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
    Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic and Molecular Characterization of Four Cases of Pediatric Salivary Secretory Carcinoma (SSC), One with ETV6-RET Fusion.
    Salgado CM; Alaggio R; Reyes-Múgica M; Zin A; de Vito R
    Head Neck Pathol; 2021 Sep; 15(3):796-802. PubMed ID: 33459993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas.
    Sams RN; Gnepp DR
    Head Neck Pathol; 2013 Mar; 7(1):64-8. PubMed ID: 23054955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).
    Drilon A; Li G; Dogan S; Gounder M; Shen R; Arcila M; Wang L; Hyman DM; Hechtman J; Wei G; Cam NR; Christiansen J; Luo D; Maneval EC; Bauer T; Patel M; Liu SV; Ou SH; Farago A; Shaw A; Shoemaker RF; Lim J; Hornby Z; Multani P; Ladanyi M; Berger M; Katabi N; Ghossein R; Ho AL
    Ann Oncol; 2016 May; 27(5):920-6. PubMed ID: 26884591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland.
    Hsieh MS; Chou YH; Yeh SJ; Chang YL
    Virchows Arch; 2015 Aug; 467(2):145-53. PubMed ID: 25976476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF; Benayed R; Hyman DM; Drilon A; Zehir A; Frosina D; Arcila ME; Dogan S; Klimstra DS; Ladanyi M; Jungbluth AA
    Am J Surg Pathol; 2017 Nov; 41(11):1547-1551. PubMed ID: 28719467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.